Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4

Biochemistry

Volumn 45, Issue 13, 2006, Pages 4240-4247

  Tanaka, Masafumi ^a   Vedhachalam, Charulatha ^b   Sakamoto, Takaaki ^a   Dhanasekaran, Padmaja ^b   Phillips, Michael C ^b   Lund Katz, Sissel ^b,c   Saito, Hiroyuki ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; DISEASE CONTROL; FLUORESCENCE; LIPIDS; MOLECULAR STRUCTURE; TOXICITY;

ALZHEIMER'S DISEASE; CARBOXYL-TERMINAL TRUNCATION; HUMAN APOLIPOPROTEIN E4; LIPID-FREE STRUCTURE;

PROTEINS;

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; FLUORESCENT DYE; GUANIDINE HYDROCHLORIDE; LIPID EMULSION; MUTANT PROTEIN; TRYPTOPHAN;

ALPHA HELIX; ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CIRCULAR DICHROISM; FLUORESCENCE; HUMAN; HYDROPHOBICITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; THERMOSTABILITY;

AMINO ACID SEQUENCE; ANILINO NAPHTHALENESULFONATES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHROMATOGRAPHY, GEL; EMULSIONS; GUANIDINE; HUMANS; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, FLUORESCENCE; TRYPTOPHAN;

EID: 33645546659     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi060023b     Document Type: Article

References (60)

1. Mahley, R. W. (1988) Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology, Science 240, 622-630.
2. Weisgraber, K. H. (1994) Apolipoprotein E: structure-function relationships, Adv. Protein Chem. 45, 249-302.
3. Mahley, R. W., and Rail, S. C., Jr. (2000) Apolipoprotein E: far more than a lipid transport protein, Annu. Rev. Genomics Hum. Genet. 1, 507-537.
4. Strittmatter, W. J., and Bova Hill, C. (2002) Molecular biology of apolipoprotein E, Curr. Opin. Lipidol. 13, 119-123.
5. Strittmatter, W. J., and Roses, A. D. (1995) Apolipoprotein E and Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 92, 4725-4727.
6. Weisgraber, K. H., and Mahley, R. W. (1996) Human apolipoprotein E: the Alzheimer's disease connection, FASEB J. 10, 1485-1494.
7. Ashford, J. W. (2004) APOE genotype effects on Alzheimer's disease onset and epidemiology, J. Mol. Neurosci. 23, 157-165.
8. Huang, Y., Weisgraber, K. H., Mucke, L., and Mahley, R. W. (2004) Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease, J. Mol. Neurosci. 23, 189-204.
9. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., and Roses, A. D. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 90, 1977-1981.
10. Holtzman, D. M., Bales, K. R., Tenkova, T., Pagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., and Paul, S. M. (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A. 97, 2892-2897.
11. Teasdale, G. M., Nicoll, J. A., Murray, G., and Fiddes, M. (1997) Association of apolipoprotein E polymorphism with outcome after head injury, Lancet 350, 1069-1071.
12. Roses, A. D. (1998) Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg, Ann. N.Y. Acad. Sci. 855, 738-743.
13. Saito, H., Lund-Katz, S., and Phillips, M. C. (2004) Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins, Prog. Lipid Res. 43, 350-380.
14. Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., and Agard, D. A. (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E, Science 252, 1817-1822.
15. Narayanaswami, V., and Ryan, R. O. (2000) Molecular basis of exchangeable apolipoprotein function, Biochim. Biophys. Acta 1483, 15-36.
16. Westerlund, J. A., and Weisgraber, K. H. (1993) Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization, J. Biol. Chem. 268, 15745-15750.
17. Segrest, J. P., Garber, D. W., Brouillette, C. G., Harvey, S. C., and Anantharamaiah, G. M. (1994) The amphipathic α-helix: a multifunctional structural motif in plasma apolipoproteins, Adv. Protein Chem. 45, 303-369.
18. Saito, H., Dhanasekaran, P., Baldwin, F., Weisgraber, K. H., Lund-Katz, S., and Phillips, M. C. (2001) Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles, J. Biol. Chem. 276, 40949-40954.
19. Perugini, M. A., Schuck, P., and Howlett, G. J. (2000) Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid, J. Biol. Chem. 275, 36758-36765.
20. Fan, D., Li, Q., Korando, L., Jerome, W. G., and Wang, J. (2004) A monomeric human apolipoprotein E carboxyl-terminal domain, Biochemistry 43, 5055-5064.
21. Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., and Agard, D. A. (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms, J. Biol. Chem. 269, 22358-22365.
22. Dong, L. M., and Weisgraber, K. H. (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low-density lipoproteins, J. Biol. Chem. 271, 19053-19057.
23. Hatters, D. M., Budamagunta, M. S., Voss, J. C., and Weisgraber, K. H. (2005) Modulation of apolipoprotein E structure by domain interaction: differences in lipid-bound and lipid-free forms, J. Biol. Chem. 280, 34288-34295.
24. Drury, J., and Narayanaswami, V. (2005) Examination of lipid-bound conformation of apolipoprotein E4 by pyrene excimer fluorescence, J. Biol: Chem. 280, 14605-14610.
25. Saito, H., Dhanasekaran, P., Baldwin, F., Weisgraber, K. H., Phillips, M. C., and Lund-Katz, S. (2003) Effects of polymorphism on the lipid interaction of human apolipoprotein E, J. Biol. Chem. 278, 40723-40729.
26. Xu, Q., Brecht, W. J., Weisgraber, K. H., Mahley, R. W., and Huang, Y. (2004) Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer, J. Biol. Chem. 279, 25511-25516.
27. Raffai, R. L., Dong, L. M., Farese, R. V., Jr., and Weisgraber, K. H. (2001) Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E, Proc. Natl. Acad. Sci. U.S.A. 98, 11587-11591.
28. Huang, Y., Liu, X. Q., Wyss-Coray, T., Brecht, W. J., Sanan, D. A., and Mahley, R. W. (2001) Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons, Proc. Natl. Acad. Sci. U.S.A. 98, 8838-8843.
29. Brecht, W. J., Harris, F. M., Chang, S., Tesseur, I., Yu, G. Q., Xu, Q., Dee Fish, J., Wyss-Coray, T., Buttini, M., Mucke, L., Mahley, R. W., and Huang, Y. (2004) Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice, J. Neurosci. 24, 2527-2534.
30. Harris, F. M., Brecht, W. J., Xu, Q., Tesseur, I., Kekonius, L., Wyss-Coray, T., Fish, J. D., Masliah, E., Hopkins, P. C., Scearce-Levie, K., Weisgraber, K. H., Mucke, L., Mahley, R. W., and Huang, Y. (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice, Proc. Natl. Acad. Sci. U.S.A. 100, 10966-10971.
31. Chang, S., Ma, T. R., Miranda, R. D., Balestra, M. E., Mahley, R. W., and Huang, Y. (2005) Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc. Natl. Acad. Sci. U.S.A. 102, 18694-18699.
32. Morrisett, J. D., David, J. S., Pownall, H. J., and Gotto, A. M., Jr. (1973) Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine, Biochemistry 12, 1290-1299.
33. Acharya, P., Segall, M. L., Zaiou, M., Morrow, J., Weisgraber, K. H., Phillips, M. C., Lund-Katz, S., and Snow, J. (2002) Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism, Biochim. Biophys. Acta 1584, 9-19.
34. Sparks, D. L., Lund-Katz, S., and Phillips, M. C. (1992) The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high-density lipoprotein particles, J. Biol. Chem. 267, 25839-25847.
35. Eftink, M. R. (2000) Use of fluorescence spectroscopy as thermodynamics tool, Methods Enzymol. 323, 459-473.
36. Saito, H., Dhanasekaran, P., Nguyen, D., Holvoet, P., Lund-Katz, S., and Phillips, M. C. (2003) Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model, J. Biol. Chem. 278, 23227-23232.
37. Lund-Katz, S., Weisgraber, K. H., Mahley, R. W., and Phillips, M. C. (1993) Conformation of apolipoprotein E in lipoproteins, J. Biol. Chem. 268, 23008-23015.
38. Lund-Katz, S., Zaiou, M., Wehrli, S., Dhanasekaran, P., Baldwin, F., Weisgraber, K. H., and Phillips, M. C. (2000) Effects of lipid interaction on the lysine microenvironments in apolipoprotein E, J. Biol. Chem. 275, 34459-34464.
39. Liu, L., Bortnick, A. E., Nickel, M., Dhanasekaran, P., Subbaiah, P. V., Lund-Katz, S., Rothblat, G. H., and Phillips, M. C. (2003) Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high-density lipoprotein particles, J. Biol. Chem. 278, 42976-42984.
40. Segrest, J. P., Jones, M. K., De Loof, H., Brouillette, C. G., Venkatachalapathi, Y. V., and Anantharamaiah, G. M. (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function, J. Lipid Res. 33, 141-166.
41. Choy, N., Raussens, V., and Narayanaswami, V. (2003) Intermolecular coiled-coil formation in human apolipoprotein E C-terminal domain, J. Mol. Biol. 334, 527-539.
42. Morrow, J. A., Segall, M. L., Lund-Katz, S., Phillips, M. C., Knapp, M., Rupp, B., and Weisgraber, K. H. (2000) Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain, Biochemistry 39, 11657-11666.
43. Morrow, J. A., Hatters, D. M., Lu, B., Hochtl, P., Oberg, K. A., Rupp, B., and Weisgraber, K. H. (2002) Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease, J. Biol. Chem. 277, 50380-50385.
44. Narayanaswami, V., Szeto, S. S., and Ryan, R. O. (2001) Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3, J. Biol. Chem. 276, 37853-37860.
45. Aggerbeck, L. P., Wetterau, J. R., Weisgraber, K. H., Wu, C. S., and Lindgren, F. T. (1988) Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains, J. Biol. Chem. 263, 6249-6258.
46. Chou, C. Y., Lin, Y. L., Huang, Y. C., Sheu, S. Y., Lin, T. H., Tsay, H. J., Chang, G. G., and Shiao, M. S. (2005) Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution, Biophys. J. 88, 455-466.
47. Weers, P. M., Narayanaswami, V., Choy, N., Luty, R., Hicks, L., Kay, C. M., and Ryan, R. O. (2003) Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability?, Biophys. Chem. 100, 481-492.
48. Li, X., Kypreos, K., Zanni, E. E., and Zannis, V. (2003) Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain, Biochemistry 42, 10406-10417.
49. Wilson, C., Mau, T., Weisgraber, K. H., Wardell, M. R., Mahley, R. W., and Agard, D. A. (1994) Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein, Structure 2, 713-718.
50. Davidson, W. S., Hazlett, T., Mantulin, W. W., and Jonas, A. (1996) The role of apolipoprotein AI domains in lipid binding, Proc. Natl. Acad. Sci. U.S.A. 93, 13605-13610.
51. Oda, M. N., Forte, T. M., Ryan, R. O., and Voss, J. C. (2003) The C-terminal domain of apolipoprotein A-I contains a lipid-sensitive conformational trigger, Nat. Struct. Biol. 10, 455-460.
52. Gorshkova, I. N., Liadaki, K., Gursky, O., Atkinson, D., and Zannis, V. I. (2000) Probing the lipid-free structure and stability of apolipoprotein A-I by mutation, Biochemistry 39, 15910-15919.
53. Silva, R. A., Hilliard, G. M., Fang, J., Macha, S., and Davidson, W. S. (2005) A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading, Biochemistry 44, 2759-2769.
54. Saito, H., Dhanasekaran, P., Nguyen, D., Deridder, E., Holvoet, P., Lund-Katz, S., and Phillips, M. C. (2004) α-Helix formation is required for high affinity binding of human apolipoprotein A-I to lipids, J. Biol. Chem. 279, 20974-20981.
55. Kypreos, K. E., van Dijk, K. W., Havekes, L. M., and Zannis, V. I. (2005) Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia, J. Biol. Chem. 280, 6276-6284.
56. Pillot, T., Goethals, M., Najib, J., Labeur, C., Lins, L., Chambaz, J., Brasseur, R., Vandekerckhove, J., and Rosseneu, M. (1999) β-Amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease, J. Neurochem. 72, 230-237.
57. Phu, M. J., Hawbecker, S. K., and Narayanaswami, V. (2005) Fluorescence resonance energy transfer analysis of apolipoprotein E C-terminal domain and amyloid β peptide (1-42) interaction, J. Neurosci. Res. 80, 877-886.
58. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., and Roses, A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 90, 8098-8102.
59. Ji, Z. S., Miranda, R. D., Newhouse, Y. M., Weisgraber, K. H., Huang, Y., and Mahley, R. W. (2002) Apolipoprotein E4 potentiates amyloid β peptide-induced lysosomal leakage and apoptosis in neuronal cells, J. Biol. Chem. 277, 21821-21828.
60. Ji, Z. S., Mullendorff, K., Cheng, I. H., Miranda, R. D., Huang, Y., and Mahley, R. W. (2006) Reactivity of Apolipoprotein E4 and Amyloid β Peptide: Lysosomal Stability and Neurodegeneration, J. Biol. Chem. 281, 2683-2692.